Plus Therapeutics
Price & Volume
Stats
See more52W Range | $0.16-$2.31 |
Market Cap | $83.8M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $5.2M |
Revenue Growth (YoY) | -4.1% |
Gross Profit (12 Mos) | -$2.3M |
Diluted EPS | -$0.96 |
News
See moreYahoo Finance • yesterday
Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium
Yahoo Finance • 8 days ago
Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ™ in Leptomeningeal Metastases
Yahoo Finance • 15 days ago
Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
About
CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
CFO | Mr. Andrew J. Sims CPA |
Address | 2710 Reed Road, Houston, TX, United States, 77051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |
